KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $1.3 million.

  • Castle Biosciences' Other Non-Current Assets fell 2998.36% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 2998.36%. This contributed to the annual value of $1.2 million for FY2024, which is 1472.22% down from last year.
  • Per Castle Biosciences' latest filing, its Other Non-Current Assets stood at $1.3 million for Q3 2025, which was down 2998.36% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Other Non-Current Assets ranged from a high of $2.7 million in Q1 2022 and a low of $792000.0 during Q1 2023
  • In the last 5 years, Castle Biosciences' Other Non-Current Assets had a median value of $1.4 million in 2023 and averaged $1.5 million.
  • As far as peak fluctuations go, Castle Biosciences' Other Non-Current Assets surged by 71959.8% in 2021, and later tumbled by 7065.58% in 2023.
  • Over the past 5 years, Castle Biosciences' Other Non-Current Assets (Quarter) stood at $1.7 million in 2021, then crashed by 35.28% to $1.1 million in 2022, then rose by 29.73% to $1.4 million in 2023, then fell by 14.72% to $1.2 million in 2024, then grew by 4.4% to $1.3 million in 2025.
  • Its Other Non-Current Assets stands at $1.3 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.